Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for adult attention-deficit/hyperactivity disorder
IRCT138808122660N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venlafaxine in attention deficit hyperactivity disorder (ADHD), sponsored by Tabriz University of Medical Sciences. Started Mar 2009; status: completed.
02
Drugs
venlafaxine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT138808122660N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138808122660N1.